Published in J Rheumatol on April 22, 1982
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med (2005) 2.82
Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol (2011) 1.38
Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres. J Neurol Neurosurg Psychiatry (2000) 1.20
Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies. J Clin Invest (1990) 1.10
HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease. Ann Rheum Dis (1987) 0.98
Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis (2011) 0.98
Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Res Ther (2011) 0.97
Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease. J Clin Invest (1989) 0.90
The long-term outcome of anti-Jo-1-positive inflammatory myopathies. J Neurol (2004) 0.85
Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins. Br Heart J (1987) 0.84
Polymyositis-dermatomyositis: a clinical review. Postgrad Med J (1989) 0.79
Rheumatology. Postgrad Med J (1991) 0.75
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36
Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol (1969) 4.45
Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol (1998) 3.68
Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine. J Biol Chem (1985) 3.60
Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera. J Immunol (1971) 3.59
Career development for women in academic medicine: Multiple interventions in a department of medicine. JAMA (1996) 3.14
Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) (1976) 3.07
Physical association of two nuclear antigens and mutual occurrence of their antibodies: the relationship of the SM and RNAprotein (MO) systems in SLE sera. J Immunol (1973) 3.07
Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen. Arthritis Rheum (1974) 2.99
Probable assignment of the Duffy blood group locus to chromosome 1 in man. Proc Natl Acad Sci U S A (1968) 2.74
Use of glutaraldehyde as a coupling agent for proteins and peptides. Methods Enzymol (1980) 2.73
Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum (1986) 2.39
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest (1996) 2.39
Incomplete Reiter's syndrome: discriminating features and HL-A W27 in diagnosis. Ann Intern Med (1976) 2.34
Amino acid substitution and the antigenicity of globular proteins. Adv Immunol (1975) 2.32
Serological findings in patients with "ANA-negative" systemic lupus erythematosus. Medicine (Baltimore) (1981) 2.27
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum (1980) 2.23
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest (1999) 2.14
Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. N Engl J Med (1972) 2.12
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) (1985) 2.01
Association of labial salivary gland histopathology with clinical and serologic features of connective tissue diseases. Arthritis Rheum (1990) 1.99
Genetic control of basal serum immunoglobulin E level and its effect on specific reaginic sensitivity. Proc Natl Acad Sci U S A (1974) 1.98
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum (1981) 1.97
Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody. J Clin Invest (1984) 1.90
Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum (2001) 1.87
Genetic linkage confirmed between the locus for myotonic dystrophy and the ABH-secretion and Lutheran blood group loci. Am J Hum Genet (1972) 1.82
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) (2006) 1.77
Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med (1983) 1.75
Evidence that autoimmunity in man is a Mendelian dominant trait. Am J Hum Genet (1986) 1.74
Studies in familial systemic lupus erythematosus. Medicine (Baltimore) (1976) 1.70
Association of the HL-A7 cross-reacting group with a specific reaginic antibody response in allergic man. Science (1973) 1.69
Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med (1983) 1.68
Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis. Dig Dis Sci (1989) 1.65
Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen. J Clin Invest (1990) 1.64
An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford) (2007) 1.63
The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum (1985) 1.62
Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med (1988) 1.59
Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest (1982) 1.58
Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med (1984) 1.54
The epidemiology and genetics of atopic allergy. N Engl J Med (1981) 1.54
Autoantibodies of neonatal lupus erythematosus. J Invest Dermatol (1994) 1.53
Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum (1992) 1.53
The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol (1994) 1.53
Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int (2001) 1.52
Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum (1996) 1.51
Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenic purpura, and systemic lupus erythematosus. Am J Med (1982) 1.51
The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol (1979) 1.51
The presence of masked antiribosomal P autoantibodies in healthy children. Arthritis Rheum (1998) 1.51
Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (2000) 1.50
A distinctive autoantibody profile in black female patients with lupus nephritis. Arthritis Rheum (1993) 1.50
Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science (1986) 1.50
Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence. Arch Dermatol (1991) 1.47
Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum (1988) 1.47
Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum (1999) 1.45
Linkage of the loci for the nail-patella syndrome and adenylate kinase. Am J Hum Genet (1969) 1.43
Complement component C4A and C4B levels in systemic lupus erythematosus: quantitation in relation to C4 null status and disease activity. J Rheumatol (1993) 1.42
Heterogeneity of the Ro/SSA antigen. Different molecular forms in lymphocytes and red blood cells. J Clin Invest (1989) 1.41
Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study. Am J Med (1991) 1.40
Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun (2006) 1.39
Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells. J Immunol (1991) 1.38
Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest (1992) 1.37
A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum (1989) 1.37
Problems in differentiating SLE and mixed connective-tissue disease. N Engl J Med (1976) 1.36
Incomplete Reiter's syndrome: clinical comparisons with classical triad. Ann Rheum Dis (1979) 1.34
Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum (1982) 1.33
Increased HLA A1 and diminished HLA A3 in lymphocytic colitis compared to controls and patients with collagenous colitis. Dig Dis Sci (1992) 1.31
Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med (1986) 1.31
Haptoglobin: a locus on the D1 chromosome? Am J Hum Genet (1967) 1.30
Description of a serological reaction characteristic of polymyositis. Clin Immunol Immunopathol (1976) 1.30
Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) (1984) 1.30
Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol (1984) 1.30
Current perspectives on serological reactions in SLE patients. Clin Exp Immunol (1981) 1.28
Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med (1985) 1.28
Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum (1982) 1.27
Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus. Arthritis Rheum (1979) 1.26
Idiotypic cross-reactivity between antibodies of different specificities. J Exp Med (1978) 1.24
Significance of the Ro antigen system. J Clin Immunol (1986) 1.22
Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest (1992) 1.21
HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure. J Exp Med (1982) 1.20
Immunological activity of cytochrome c. 3. Enhancement of antibody detection and immune response initiation by cytochrome c polymers. J Biol Chem (1970) 1.20
A mammalian tRNAHis-containing antigen is recognized by the polymyositis-specific antibody anti-Jo-1. Nucleic Acids Res (1983) 1.19
Anti-Ro(SS-A) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurology (1994) 1.19
Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE. Arthritis Rheum (1977) 1.18
The reactions of antibodies with hemeprotein antgens. The measurement of reaction kinetics and stoichiometry by fluorescence quenching. J Biol Chem (1969) 1.16